News

News

Lexaria Begins Nicotine Absorption Study

Kelowna, British Columbia – March 14, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”), a drug delivery platform innovator, is pleased to announce that it…

Lexaria and Neutrisci Enter Global Licensing Agreement

Kelowna, British Columbia – February 26, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces it has entered an agreement…

2017 Wrap-Up by Lexaria’s CEO

Kelowna, British Columbia – January 8, 2018 – Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces it’s been quite an amazing year for Lexaria stakeholders –…